Norian's SRS injectable bone mineral substitute entering clinicals.
This article was originally published in The Gray Sheet
Executive Summary
NORIAN'S SKELETAL REPAIR SYSTEM INJECTABLE BONE MINERAL SUBSTITUTE is entering U.S. clinical trials for treatment of distal radius wrist fractures. The 12-center randomized controlled study, cleared under an investigational device exemption, will include up to 324 patients ranging from age 45 to 80 at twelve different hospitals.